The DRUP study in Nature: taking stock of the first three years


In 2016, the Drug Rediscovery Protocol was launched in the Netherlands. This is a unique and innovative pan-cancer clinical trial that seeks to expand the use of EMA and/or FDA-approved targeted therapies beyond their approved indications. In a Nature paper, published online on 30 September, the research team now takes stock of the progress of DRUP over the first three years. 

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.